1 completed, 1 terminated, 1 withdrawn. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 1, Terminated 1, Withdrawn 1 |
Follow Lumefantrine: new trials by email Literature Review of Lumefantrine trials Research Report on Lumefantrine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| To Evaluate Efficacy, Safety, Tolerability and PK of Intravenous Cipargamin in Participants With Severe Plasmodium Falciparum Malaria Cipargamin, IV Artesunate, Coartem - Severe Malaria | Phase 2 | Completed | Novartis Pharmaceuticals | 254 | 2022-03-07 | 2026-04-09 |
| A Study to Assess the Safety and Efficacy of 5-aminolevulinic Acid Hydrochloride (5-ALA HCl) and Sodium Ferrous Citrate (SFC) Added on Artemisinin-based Combination Therapy (ACT) in Adult Patients With Uncomplicated Malaria 5-aminolevulinic acid hydrochloride (5-ALA HCl) 600 mg QD, Sodium ferrous citrate (SFC) 472 mg QD, Artemisinin-based combination (ACT) - Malaria | Phase 2 | Withdrawn | Neopharma Japan Co., Ltd. | 2019-09-06 | 2020-03-03 | |
| Anti-parasitic Activity and Safety Assessment of SAR97276A in Children With Uncomplicated Malaria SAR97276A, arthemeter + lumefantrine (ACTs) - Malaria | Phase 2 | Terminated | Sanofi | 20 | 2011-10-01 | 2012-12-13 |
Malaria (3)
Neopharma Japan Co., Ltd. (1) · Novartis Pharmaceuticals (1) · Sanofi (1)
Burkina Faso (2) · Kenya (2) · Benin (1) · Côte d’Ivoire (1) · Democratic Republic of the Congo (1) · Gabon (1) · Mozambique (1) · Rwanda (1) · Uganda (1)